Physician profile

David Barnes Carmack

General Practice · Jbsa Ft Sam Houston, TX

NPI 1154017556

$1,122.09

in general payments reported to CMS, 2019-2025

5 companies · $768 in 2025

The $768 reported for 2025 was more than what 89% of General Practice providers received nationally (typical 2025 total: $105).

See the full distribution for General Practice

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,122.09

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $572.33 2024-2025 Hoffmann, T2 Alpha, Claw II
Mission Medical Distribution, LLC $259.12 2024-2025
Orthofix Medical, INC. $144.85 2025 Vu A-Pod Prime Nanometalene
Globus Medical, INC. $128.53 2025 Harvest
Smith+Nephew, INC. $17.26 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David Barnes Carmack

$1,122.09

in general payments reported 2019-2025

Years
2024-2025
Top company
Stryker Corporation
Context
The $768 reported for 2025 was more than what 89% of General Practice providers received nationally (typical 2025 total: $105).

https://glasscript.com/doctor/11696290/david-barnes-carmack

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.